Global Intensity Modulated Radiotherapy Market Size study & Forecast, by Radiation Type (Proton radiation, Electron radiation, Photon radiation, Carbon-Ion radiation), by Application (Prostate cancer, Lung cancer, Breast cancer, Brain cancer, Gynecologica

Global Intensity Modulated Radiotherapy Market Size study & Forecast, by Radiation Type (Proton radiation, Electron radiation, Photon radiation, Carbon-Ion radiation), by Application (Prostate cancer, Lung cancer, Breast cancer, Brain cancer, Gynecological cancers, Gastrointestinal cancers, Other cancers), by End User (Hospitals, Independent Radiotherapy Centers) and Regional Analysis, 2023-2030

Global Intensity Modulated Radiotherapy Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Intensity Modulated Radiotherapy (IMRT) is a type of advanced radiation therapy technique used in the treatment of cancer. In contradistinction to conventional radiotherapy, which delivers a uniform dose of radiation to the entire tumor and surrounding tissues, IMRT allows for the precise modulation of the intensity of the radiation beams. This modulation enables the delivery of higher radiation doses to the tumor while minimizing the dose to nearby healthy tissues and organs. The key factors driving the market growth are the increasing incidence of cancer, rising healthcare expenditure, and increasing adoption of radiation therapy as a primary treatment option for cancer that is anticipated to support the market growth.

Additionally, the increasing incidence of cancer has led to a growing demand for advanced and effective treatment options, including radiation therapy. Intensity Modulated Radiotherapy allows for the precise targeting of cancer cells while minimizing damage to surrounding healthy tissues. This precision is crucial in the treatment of various types of cancers, and it is particularly beneficial when dealing with tumors located near critical organs or structures. Thus, the rising incidence of cancer is anticipated to support the market growth. According to Statista, approx. 19.2 million new cases of cancer were reported worldwide in 2020. In the year 2040, it is anticipated that there would be about 30.2 million incident cases. Moreover, advancements in radiation therapy technologies and growing research and development are anticipated to create a lucrative opportunity for the market over the projected period. However, the dearth of skilled radiologists/oncologists for operating automated radiotherapy equipment stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Intensity Modulated Radiotherapy Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising prevalence of cancer and high demand for timely diagnosis, growing geriatric population, increasing healthcare expenditure, and growing technological developments in healthcare. Whereas, the Asia Pacific is expected to grow with the highest CAGR over the forecast period, owing to factors such as the rising incidence of cancer, growing awareness and education, increasing healthcare spending, and collaborations between healthcare institutions, technology providers, and research organizations can drive innovation and the adoption of advanced treatment modalities.

Major market player included in this report are:
Siemens Healthineers AG
Elekta
Accuray Incorporated
IBA Worldwide
Hitachi, Ltd.
Mevion Medical Systems
Koninklijke Philips N.V.
Raysearch Laboratories
Brainlab AG
Varian Medical Systems, Inc.

Recent Developments in the Market:
 NA

Global Intensity Modulated Radiotherapy Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Radiation Type, Application, End User, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Radiation Type:
Proton radiation
Electron radiation
Photon radiation
Carbon-Ion radiation

By Application:
Prostate cancer
Lung cancer
Breast cancer
Brain cancer
Gynecological cancers
Gastrointestinal cancers
Other cancers

By End User:
Hospitals
Independent Radiotherapy Centers

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Siemens Healthineers AG
Elekta
Accuray Incorporated
IBA Worldwide
Hitachi, Ltd.
Mevion Medical Systems
Koninklijke Philips N.V.
Raysearch Laboratories
Brainlab AG
Varian Medical Systems, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.